Amgen Inc.
AMGN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $9,557,000 | $9,167,000 | $8,149,000 | $9,086,000 |
| % Growth | 4.3% | 12.5% | -10.3% | – |
| Cost of Goods Sold | $3,082,000 | $3,011,000 | $2,968,000 | $3,112,000 |
| Gross Profit | $6,475,000 | $6,156,000 | $5,181,000 | $5,974,000 |
| % Margin | 67.8% | 67.2% | 63.6% | 65.7% |
| R&D Expenses | $1,900,000 | $1,744,000 | $1,486,000 | $1,724,000 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $1,720,000 | $1,691,000 | $1,687,000 | $1,878,000 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $329,000 | $77,000 | $830,000 | $61,000 |
| Operating Expenses | $3,949,000 | $3,512,000 | $4,003,000 | $3,663,000 |
| Operating Income | $2,526,000 | $2,644,000 | $1,178,000 | $2,311,000 |
| % Margin | 26.4% | 28.8% | 14.5% | 25.4% |
| Other Income/Exp. Net | $1,395,000 | -$1,076,000 | $795,000 | -$1,529,000 |
| Pre-Tax Income | $3,921,000 | $1,568,000 | $1,973,000 | $782,000 |
| Tax Expense | $705,000 | $136,000 | $243,000 | $155,000 |
| Net Income | $3,216,000 | $1,432,000 | $1,730,000 | $627,000 |
| % Margin | 33.7% | 15.6% | 21.2% | 6.9% |
| EPS | 5.98 | 2.66 | 3.22 | 1.17 |
| % Growth | 124.8% | -17.4% | 175.2% | – |
| EPS Diluted | 5.93 | 2.65 | 3.2 | 1.16 |
| Weighted Avg Shares Out | 538,000 | 538,000 | 538,000 | 540,517 |
| Weighted Avg Shares Out Dil | 542,000 | 541,000 | 541,000 | 542,000 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $685,000 | $708,000 | $723,000 | $747,000 |
| Depreciation & Amortization | $1,307,000 | $1,341,000 | $1,387,000 | $1,397,000 |
| EBITDA | $5,913,000 | $3,617,000 | $4,083,000 | $2,926,000 |
| % Margin | 61.9% | 39.5% | 50.1% | 32.2% |